Shares of Metsera (MTSR), which had been halted ahead of the company announcing that a revised proposal that Metsera received from Novo Nordisk A/S (NVO) to acquire Metsera constitutes a “Superior Company Proposal” as defined in Metsera’s existing Merger Agreement with Pfizer (PFE), is scheduled to resume trading at 9:50 am ET, with quotation to resume at 9:45 am ET, according to Nasdaq.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Metsera receives amended ‘superior’ proposal from Novo Nordisk
- Metsera says Novo Nordisk proposal values company at approx. $10B
- Metsera Inc trading halted, news pending
- Is Pfizer (PFE) a Good Stock to Buy before Earnings?
- Novo Nordisk’s Attempt to Buy Metsera is Anticompetitive, Says Pfizer in Second Lawsuit